<DOC>
	<DOCNO>NCT01275794</DOCNO>
	<brief_summary>The purpose study assessment glycemic control physicians satisfaction result DM2 OAD monotherapy</brief_summary>
	<brief_title>Screening Epidemiological Program Compensation Evaluation Diabetes Mellitus Type 2 ( DMT2 ) Patients Oral Anti-diabetic ( OAD ) Monotherapy Physicians Satisfaction Their Usage</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients establish diagnosis T2D Experience therapy one OAD 6 month 5 year registration Program Experience therapy two OADs and/or insulin therapy and/or incretin mimetics ( exenatide ) time registration Program Absence change HbAc1 level last year registration Program</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>